Structures by: Kavitha C. N.
Total: 58
1-(3,5-dinitrobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H18N4O6
IUCrData (2020) 5, 11 x201523
a=25.348(2)Å b=7.3059(5)Å c=19.3470(10)Å
α=90° β=94.190(6)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium 3,5-dinitrobenzoate monohydrate
C7H3N2O6,C3H6N3,H2O
Acta Crystallographica Section E (2021) 77, 1 34-41
a=6.6864(7)Å b=8.1857(9)Å c=12.6490(10)Å
α=79.424(9)° β=85.583(9)° γ=75.586(9)°
Bis(3-amino-1<i>H</i>-pyrazol-2-ium) fumarate—–fumaric acid (1/1) 2C~3~H~6~N~3~^+^\χdotC~4~H~2~O~4~^2-^\χdotC~4~H~4~O~4~, (II). The reaction of 3-amino-1<i>H</i>-pyrazole with a dilute solution of nitric acid in methanol yields an second, orthorhombic polymorph of 3-amino-1<i>H</i>-pyrazol-2-ium nitrate, C~3~H~6~N~3~^+^\χdotNO~3~^-^
2(C3H6N3),C4H2O42,C4H4O4
Acta Crystallographica Section E (2021) 77, 1 34-41
a=8.5410(4)Å b=14.0507(7)Å c=7.5137(4)Å
α=90° β=98.827(6)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium nitrate
C3H6N3,NO3
Acta Crystallographica Section E (2021) 77, 1 34-41
a=7.2700(10)Å b=9.907(2)Å c=8.551(2)Å
α=90° β=90° γ=90°
1-(4-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.3286(6)Å b=11.3388(7)Å c=20.3040(10)Å
α=90° β=90° γ=90°
1-(4-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=10.9626(5)Å b=11.3258(6)Å c=14.8234(7)Å
α=90° β=104.520(5)° γ=90°
1-(4-Chlorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19ClN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=29.7690(10)Å b=11.3173(4)Å c=20.4028(8)Å
α=90° β=90° γ=90°
1-(2-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4510(10)Å b=11.199(3)Å c=19.138(5)Å
α=90° β=99.59(2)° γ=90°
1-(4-Bromobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19BrN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=15.0779(7)Å b=11.2868(6)Å c=20.5297(9)Å
α=90° β=90° γ=90°
1-(3-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4528(4)Å b=17.1306(9)Å c=27.9030(10)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4010(10)Å b=7.8880(10)Å c=15.410(3)Å
α=100.28(2)° β=94.400(10)° γ=94.140(10)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4313(5)Å b=7.9163(5)Å c=15.5212(9)Å
α=101.565(5)° β=94.780(5)° γ=92.691(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.1129(4)Å b=11.2722(7)Å c=12.5923(8)Å
α=69.852(5)° β=74.681(5)° γ=79.121(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 2-fluorobenzoate
C11H17N2O,C7H4FO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=19.9400(10)Å b=10.2705(7)Å c=9.0148(7)Å
α=90° β=109.663(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.9974(8)Å b=27.611(2)Å c=8.5972(9)Å
α=90° β=106.400(10)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=6.9824(2)Å b=13.2292(4)Å c=19.4903(7)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.0101(4)Å b=13.3796(6)Å c=19.5524(6)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-methylbenzoate
C11H17N2O,C8H7O2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8260(10)Å b=10.320(2)Å c=12.055(3)Å
α=78.37(2)° β=78.27(2)° γ=73.83(2)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-aminobenzoate
C11H17N2O,C7H6NO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=14.9220(10)Å b=7.6951(5)Å c=15.5600(10)Å
α=90° β=106.911(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-nitrobenzoate
C11H17N2O,C7H4NO4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.5174(5)Å b=7.9761(5)Å c=29.860(2)Å
α=90° β=97.322(6)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 3,5-dinitrobenzoate dihydrate
C11H17N2O,C7H3N2O6,2(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8448(6)Å b=11.4635(9)Å c=12.0747(9)Å
α=94.406(7)° β=105.075(8)° γ=93.717(7)°
4-(2-Methoxyphenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C11H17N2O,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=9.4151(5)Å b=9.8721(5)Å c=10.9572(5)Å
α=77.524(4)° β=81.360(5)° γ=81.002(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen fumarate
C11H17N2O,0.5(C4H3O4),C1.14H0.86O1.14,C0.86H0.64O0.86)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8546(4)Å b=8.9626(6)Å c=11.2056(8)Å
α=79.043(5)° β=87.715(5)° γ=85.840(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen maleate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=11.1076(6)Å b=11.1164(6)Å c=13.7649(7)Å
α=80.353(5)° β=78.353(5)° γ=74.406(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate 1.698-hydrate
C11H17N2O,C4H5O6,1.698(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4790(10)Å b=7.0650(10)Å c=17.788(3)Å
α=90° β=101.58(2)° γ=90°
Clozapinium hydrogen bis(3,5-dinitrobenzoate)
C18H20ClN4,C7H3N2O6,C7H4N2O6
Acta Crystallographica Section E (2020) 76, 10 1629-1633
a=7.4102(6)Å b=24.629(2)Å c=18.4460(10)Å
α=90° β=98.478(6)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 2-bromobenzoate 0.353-hydrate
C10H14FN2,C7H4BrO2,0.353(H2O)
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=7.2584(8)Å b=9.3470(10)Å c=13.767(2)Å
α=101.140(10)° β=95.980(10)° γ=109.440(10)°
4-(4-Fluorophenyl)piperazin-1-ium 2-fluorobenzoate monohydrate
C10H14FN2,C7H4FO2,H2O
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=6.5873(5)Å b=7.6616(6)Å c=17.3399(9)Å
α=97.842(6)° β=90.378(6)° γ=95.540(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-iodobenzoate
C10H14FN2,C7H4IO2
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=9.8892(3)Å b=11.6831(7)Å c=16.4547(9)Å
α=106.776(5)° β=93.327(4)° γ=104.874(4)°
4-(4-Fluorophenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C10H14FN2,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=16.658(2)Å b=6.6734(6)Å c=17.553(3)Å
α=90° β=117.84(2)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 3,5-dinitrobenzoate
C10H14FN2,C7H3N2O6
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=19.8710(10)Å b=7.3420(7)Å c=26.306(2)Å
α=90° β=94.540(8)° γ=90°
Clozapinium 3,5-dinitrobenzoate dimethyl sulfoxide monosolvate
C18H20ClN4,C7H3N2O6,C2H6OS
Acta Crystallographica Section E (2015) 71, 4 406-413
a=15.3593(2)Å b=15.7685(2)Å c=11.8679(2)Å
α=90° β=91.8097(14)° γ=90°
Clozapinium hydrogen maleate 0.21-hydrate
C18H20ClN4,C4H3O4,0.21(H2O)
Acta Crystallographica Section E (2015) 71, 4 406-413
a=9.7166(3)Å b=9.9699(2)Å c=23.1059(6)Å
α=90° β=96.800(3)° γ=90°
Clozapinium 2-hydroxybenzoate
C18H20ClN4,C7H5O3
Acta Crystallographica Section E (2015) 71, 4 406-413
a=17.4296(5)Å b=15.3728(5)Å c=8.6359(3)Å
α=90° β=90.325(3)° γ=90°
Bis-[1-(3-chlorophenyl)piperazinium]dipicrate picric acid
2(C10H14ClN2),2(C6H2N3O7),C6H3N3O7
Acta Crystallographica Section E (2014) 70, 11 o1210-o1211
a=11.2213(6)Å b=14.6239(7)Å c=14.1804(8)Å
α=90° β=104.405(5)° γ=90°
Flunarizinium nicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section C (2014) 70, 8
a=10.8536(4)Å b=10.8103(4)Å c=11.3901(4)Å
α=90° β=92.717(2)° γ=90°
Flunarizinediium bis(4-toluenesulfonate) dihydrate
C26H28F2N22,2(C7H7O3S),2H2O
Acta Crystallographica Section C (2014) 70, 8
a=10.0546(5)Å b=14.8338(6)Å c=26.9437(12)Å
α=90° β=106.497(3)° γ=90°
Flunarizinium isonicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section E (2014) 70, 6 o681-o682
a=11.0023(3)Å b=10.6435(3)Å c=11.3393(3)Å
α=90° β=92.481(3)° γ=90°
1(2-Furoyl)piperazinium 3,5-dinitrobenzoate
C9H13N2O2,C7H3N2O6
Acta Crystallographica Section E (2014) 70, 6 o700-o701
a=9.6060(2)Å b=10.4572(2)Å c=33.8766(7)Å
α=90° β=90° γ=90°
Bis-[1-(benzo[1,3]dioxol-5-yl-methyl)piperazinyl]methane
C25H32N4O4
Acta Crystallographica Section E (2013) 69, 11 o1669
a=38.8025(10)Å b=9.7675(2)Å c=6.09571(13)Å
α=90° β=90° γ=90°
<i>N</i>-(1<i>H</i>-Indol-3-ylmethylidene)-4-methylpiperazin-1-amine
C14H18N4
Acta Crystallographica Section E (2013) 69, 11 o1706
a=7.5630(5)Å b=6.5593(4)Å c=13.2319(9)Å
α=90° β=100.072(6)° γ=90°
1-[4-(4-Hydroxyphenyl)piperazin-1-yl]ethanone
C12H16N2O2
Acta Crystallographica Section E (2013) 69, 11 o1671
a=6.13183(19)Å b=12.0106(4)Å c=14.8704(5)Å
α=90° β=94.025(3)° γ=90°
1-Piperonylpiperazinium picrate
C12H17N2O2,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 2 o208-o209
a=12.0864(2)Å b=6.96981(11)Å c=23.4898(4)Å
α=90° β=96.5141(17)° γ=90°
4-Diphenylmethyl-1-[(<i>E</i>)-3-phenylprop-2-en-1-yl]piperazin-1-ium (2<i>Z</i>)-3-carboxyprop-2-enoate
C26H29N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 1 o142-o143
a=21.9467(4)Å b=10.43729(18)Å c=11.20623(19)Å
α=90.00° β=90.0458(15)° γ=90.00°
2-Methyl-4-(4-methylpiperazin-4-ium-1-yl)-10<i>H</i>- thieno[2,3-<i>b</i>][1,5]benzodiazepinium bis(2,4,6-trinitrophenolate)
C17H22N4S2,2(C6H2N3O7)
Acta Crystallographica Section E (2013) 69, 2 o232-o233
a=22.1660(4)Å b=12.7349(2)Å c=23.3951(4)Å
α=90.00° β=90.00° γ=90.00°
{2-[(4-Nitrobenzylidene)amino]-4,5,6,7-tetrahydro-1-benzothiophen-3-yl}(phenyl)methanone
C22H18N2O3S
Acta Crystallographica Section E (2014) 70, 6 o738-o739
a=4.61595(13)Å b=17.6844(4)Å c=11.7068(3)Å
α=90° β=91.285(3)° γ=90°
4-acetylpiperazinium picrate
C6H13N2O,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 6 o717-o718
a=6.6843(7)Å b=11.5971(12)Å c=20.131(2)Å
α=90° β=90.000(4)° γ=90°
(3-Chloropropyl)triphenylphosphonium bromide
C21H21ClP,Br
Acta Crystallographica Section E (2012) 68, 11 o3115
a=11.0708(2)Å b=10.0435(2)Å c=17.5740(4)Å
α=90.00° β=104.9730(10)° γ=90.00°
Flunarizinium succinate
C26H27F2N2,C4H5O4
Acta Crystallographica Section E (2013) 69, 2 o260-o261
a=10.7824(2)Å b=10.6270(2)Å c=11.2364(2)Å
α=90.00° β=91.6780(10)° γ=90.00°
Cinnarizinium bis(<i>p</i>-toluenesulfonate) dihydrate
C26H30N22,2(C7H7O3S),2(H2O)
Acta Crystallographica Section E (2013) 69, 4 o485-o486
a=10.0845(2)Å b=14.6026(3)Å c=25.8591(6)Å
α=90.00° β=93.414(2)° γ=90.00°
(4-Methylpiperazin-1-yl)-(2,3,4-trimethoxybenzylidene)amine
C15H23N3O3
Acta Crystallographica Section E (2014) 70, 4 o500
a=7.84207(14)Å b=14.2305(3)Å c=27.6218(5)Å
α=90° β=90° γ=90°
{2-[(2-Hydroxy-benzylidene)-amino]-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl}- phenyl-methanone
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 4 o476-o477
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
[2-(Benzylideneamino)-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl](phenyl)methanone
C22H19NOS
Acta Crystallographica Section E (2014) 70, 5 o507-o508
a=8.78760(16)Å b=14.0091(3)Å c=14.4120(2)Å
α=90° β=94.8913(17)° γ=90°
1-Piperonylpiperazinium p-chlorobenzoate
C12H17N2O2,C7H4ClO2
Acta Crystallographica Section E (2014) 70, 3 o283-o284
a=16.9967(6)Å b=8.5990(3)Å c=12.4150(5)Å
α=90° β=90.923(3)° γ=90°
Flunarizinium hydrogen maleate
C26H27F2N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 8 o1344
a=22.1215(5)Å b=10.8620(2)Å c=11.3215(2)Å
α=90° β=98.879(2)° γ=90°
4-Methyl-<i>N</i>-(4-nitrobenzylidene)piperazin-1-amine
C12H16N4O2
Acta Crystallographica Section E (2013) 69, 11 o1687-o1688
a=27.9353(14)Å b=5.9247(3)Å c=18.7763(7)Å
α=90° β=126.527(3)° γ=90°
1-Piperonylpiperazinium 4-nitrobenzoate monohydrate
C12H17N2O2,C7H4NO4,H2O
Acta Crystallographica Section E (2014) 70, 3 o270-o271
a=6.0745(5)Å b=12.0617(11)Å c=13.4817(10)Å
α=92.561(7)° β=98.753(7)° γ=93.326(7)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2-[(<i>E</i>)-(2-hydroxybenzylidene)amino]acetamide
C22H19ClN2O3S
Acta Crystallographica Section E (2014) 70, 9 o1011-o1012
a=9.7888(2)Å b=16.9476(3)Å c=12.2863(3)Å
α=90° β=90.6654(19)° γ=90°